The FDA has approved Ctexli for the treatment of cerebrotendinous xanthomatosis (CTX), a rare lipid storage disease, in ...

Discover how this diabetes drug is revolutionizing heart health. Learn about its surprising benefits in reducing cardiovascular risks and mortality.

EXCLUSIVE: The parents of two siblings with a life-limiting condition are waiting in agony to find out if health chiefs will ...

The vast majority of people who have a substance use disorder (SUD) never seek treatment. At most, 10% of adults with a drug or alcohol use disorder have entered any type of inpatient or outpatient ...

The investigational new drug application for Zabalafin Hydrogel for the treatment of mild to moderate atopic dermatitis has ...

The Food and Drug Administration approved Mirum Pharmaceuticals' Ctexli to treat Cerebrotendinous Xanthoma, a very rare lipid-storage disease. The approval makes Ctexli, or chenopod, the first ...

The U.S. Food and Drug Administration approved Mirum Pharmaceuticals' genetic disorder drug on Friday, making it the first ...

SMA Healthcare has announced an expansion at its new Marion County facility. The company is adding more than 45 residential beds to treat patients living with substance use disorders. They will be ...

The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the ...

Pfizer is pulling further away from the gene therapy field with its decision to discontinue hemophilia product Beqvez. | ...

With PEPFAR seemingly now focused primarily on the treatment of existing patients ... The semaglutide shortage has officially ended in the US—which means the GLP-1 drug industry is about to undergo ...

Indeed, the pathogen seems like ancient history — but as recent developments indicate, tuberculosis isn’t done with us yet.